Ken Research - Vietnam Pharmaceutical Import And Export | Page 2

self-medication culture will continue to drive OTC drugs sector at least in the near
future. Antibiotics, Vitamins and dietary supplements will continue to attract heavy
demand through OTC channel.
Analysts at Ken Research in their latest publication “Vietnam Pharmaceutical
Market Outlook To 2022 - by Generic and Patented drugs, by Prescribed Drugs
and OTC Drugs and Therapeutic Drugs (Metabolism and Nutritional Medicine,
Cardiovascular, Central Nervous System, System Infection, Oncology,
Musculoskeletal, Respiratory” believe that incline in demand for hepatic treatment,
rise in health supplements and increasing demand for traditional / herbal medicines
will have positive impact on market.
Vietnam Pharmaceutical market is expected to register positive CAGR of around
15.6% during the period 2017-2022. R&D investment and investment in local
production of APIs will have positive impact on the demand for Pharmaceutical
products.
Public procurement of drugs is done through bidding in which any company is free
to submit proposal. Domestic manufacturers in the country produce generics with
very less investment in R&D activities, presenting low barriers to entry for any new
player. The government has increasingly favored generic drugs produced locally in
the recent procurement biddings. Foreign companies are increasingly investing in
developing manufacturing capabilities in Vietnam.
Keywords
Pharmaceutical Market in Vietnam
Vietnam Pharmaceutical Market
Vietnam Generic Drugs Revenue
Vietnam Patented Drug Revenue
Prescribed Drug Market Vietnam
OTC Medicine Sales Vietnam
Growth Pharmaceutical Sales Vietnam
Challenges Vietnam Pharmaceutical
Therapeutic Drug Sales Vietnam
Vietnam and Dietary Supplement Sales Vietnam
Antibiotic sales Vietnam
Vitamin Sales Vietnam
Vietnam Pharmaceutical Competition
Future Pharmaceutical Vietnam
Launch of New Drugs in Vietnam
Drugs Procured by Public Hospitals in Vietnam
Comparative Analysis of Pharmaceutical Companies in Vietnam
DHG Pharma Vietnam Revenue